Cyclophosphamide, TAPA-Pulsed Dendritic Cell Therapy and Imiquimod in Progressive and/or Refractory Solid Malignancies

NCT02224599 · clinicaltrials.gov ↗

PHASE1,PHASE2

Phase

TERMINATED

Status

3

Enrollment

INDUSTRY

Sponsor class

Stopped Sponsor decision to terminate study due to poor accrual

Conditions

Progressive Solid Malignancies
Refractory Solid Malignancies
Cancer

Interventions

BIOLOGICAL: TAPA-pulsed DC vaccine
DRUG: Cyclophosphamide Pill
DRUG: Imiquimod Topical Cream

Sponsor

Kiromic BioPharma Inc.